赛诺医疗：预计2025年上半年净利润同比增长296.54%

Core Viewpoint - Sino Medical expects a significant increase in net profit for the first half of 2025, projecting a year-on-year growth of 296.54% [1] Financial Performance - The projected operating revenue for the period from January 1 to June 30, 2025, is 240 million yuan, representing a year-on-year increase of 12.53% [1] - The net profit attributable to shareholders is expected to be 13.84 million yuan, with a year-on-year growth of 296.54% [1] - The net profit after deducting non-recurring gains and losses is projected to be 7.98 million yuan, reflecting a year-on-year increase of 163.35% [1] Business Drivers - The growth in performance is primarily driven by a significant increase in sales of two coronary stent products and coronary balloon products that have entered the centralized procurement range [1] - The neuro-interventional business has maintained steady growth [1] - Operating costs have increased slightly year-on-year, while sales and R&D expenses have decreased [1] - Management expenses have increased year-on-year, and there has been a significant decline in investment income and asset impairment losses [1]